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Gold compounds are among the few therapeutic agents that can cause remission of aggressive
rheumatoid arthritis. Although the mechanism for their toxicity and efficacy is unknown, gold
levels in blood have been emphasized recently. In this report, we describe a systematic method
to study the gold interaction with red blood cells and its distribution in the cell. Flow injection
analysis (FIA) and high performance liquid chromatography HPLC) with gold-specific inductively
coupled plasma-mass spectrometry (ICP-MS) detection are used.
Blood samples from patients being treated with Myochrysine were used to monitor the gold
levels in red blood cells. Using FIA and ICP-MS, we have observed that different patients on the
same regimen of drug injections differ significantly in the distribution of gold in their blood.
Although the sera of these patients generally exhibit similar levels, the gold levels in their red
blood cells are very different, which may reflect the fact that different patients have different
responses to the drugs. The gold levels in serum can be as high as 2.5 ppm and reach
"equilibrium" values after about 30 days therapy. Gold levels in red blood cells are quite variable,
400 ppb for one patient and 2.4 ppm for another. To determine the intracellular binding sites for
gold, high and low molecular weight fractions were studied using HPLC-ICP-MS. Size exclusion
separations show that the majority of the protein-bound gold is not bound to hemoglobin, but to a
high molecular weight fraction of approximately 300,000 Da. Low molecular weight species in the
red blood cell lysates were isolated by using a centrifilter with a molecular weight cutoff of 10, 000
Da, then separated by C18 reversed-phase ion pairing chromatography. One of the gold species
present in the cell lysates is dicyanogold(I), which has also been identified as a free ion in patient
sera. This dicyanogold(I) represents 4% of the total gold in low molecular weight, gold-containing
species in the cells. A second gold species has been tentatively identified as a
bis(glutathione)gold(I) complex.
Studies on the interaction of dicyanogold(I) with red blood cells were carried out by incubating the
cells from naive blood with this compound in vitro. When whole blood or washed red blood cells
are incubated with dicyanogold(I) most of the gold is rapidly taken up by the cells (>90% of the
gold ). Gold bound to low molecular weight species represents about 3% of the total gold in the
lysate solution. Auranofin shows similar uptake by red blood cells. This is in contrast to
Myochrysine incubations in which only 5% of the gold is found in cell lysates. The mechanism for
uptake of dicyanogold(I) is not known. One possibility is that dicyanogold(I) is taken up through
the anion channel of the red blood cell. We tested this idea by using a specific inhibitor of the
anion channel, 4,4’-diisothiocyanatostilbene-2,2’-DL-sulfonic acid, DIDS. A concentration of
DIDS up to 3mM, sufficient to block anion uptake in red blood cells, had no effect on the uptake of
gold after incubation of the red cells with dicyanogold(I) This indicates that dicyanogold(I) does
not enter md blood cells through the anion channel. Another mechanism which has been
proposed for uptake of gold complexes utilizes the so-called sulfhydryl shuttle, in which gold(I)
complexes undergo ligand exchange to bind to sulfhydryl groups in or on the membrane. In a
series of exchange reactions, the gold(I) passes through the membrane where it is then released
into the cytosol. Since hydrogen cyanide would be released in the reaction of dicyanogold(I) with
surface sulfhydryls, excess cyanide should repress this reaction. We therefore incubated red
blood cells with sodium cyanide, followed by dicyanogold(I). The results show that excess
cyanide significantly inhibits the uptake of gold, which suggests that the loss of cyanide from
dicyanogold(I) is important in red blood cell uptake of gold from dicyanogold(I) .This result is
consistent with the sulfhydryl shuttle. Experiments are in progress to test this model further.
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